Medscape is available in 5 Language Editions – Choose your Edition here.


Pediatric Osteomyelitis Follow-up

  • Author: Sabah Kalyoussef, DO; Chief Editor: Russell W Steele, MD  more...
Updated: May 02, 2016

Further Outpatient Care

See the list below:

  • Provide close follow-up care throughout treatment with weekly measurements of ESR, C-reactive protein levels, liver function tests, and CBC counts to monitor response and diagnose antibiotic-related neutropenia.
  • Oral antibiotic dosages may need to be increased to keep peak serum-cidal levels of 1:8 or greater. If serum-cidal levels are not adequate with oral antibiotics, the patient may need parenteral treatment.

Further Inpatient Care

See the list below:

  • For successful treatment, ensure that high-dose antimicrobials are used for an optimal period and provide close follow-up care for the patient. When antibiotics are used for less than 3 weeks, recurrence rates are higher.
  • Clinical response, etiologic agent, and return of the ESR and C-reactive protein levels to the reference range govern duration of treatment. Prescribe a minimum antibiotic course of 3 weeks; this is adequate except for patients with MRSA infection where 4-6 weeks of therapy are often required.
  • Once the pathogen is identified and antibiotic susceptibility results are available, consider narrowing antibiotic therapy.
  • Sequential intravenous-to-oral antibiotic regimens have proven safe and effective for treatment of bone and joint infections. Once symptoms and signs of inflammation have subsided and the ESR/CRP has started to fall, consider switching to oral antibiotics in a nontoxic child.
  • Studies have reported successful treatment of acute uncomplicated osteomyelitis with 3-5 days of intravenous antibiotics and 16-18 days of oral antibiotics.[18, 16] Further studies are needed to aid with universal recommendations. The treatment regimen of choice is based on the clinical progression and the location of the osteomyelitis in the child.
  • Ensure the following criteria are met before switching from intravenous to oral therapy:
    • Availability of etiologic agent and reliable laboratory to perform serum-cidal assay (Schlichter test)
    • Availability of oral antibiotic capable of achieving adequate serum levels; usually 2-3 times usual oral dose
    • Absence of GI disease causing poor absorption of antibiotic
    • Family compliance (critical to success)
  • In older children, giving higher oral dosages of antibiotics is often not possible because they exceed the maximum allowable doses.
  • If the patient does not meet the above criteria for high-dose oral antibiotic course, continue treatment at home after establishing a peripherally inserted central catheter (PICC) line or another reliable long-term venous access. Parents often find it easier to administer intravenous antibiotics less frequently than every 6 hours. Cefazolin (Ancef, Kefzol), ceftazidime (Ceptaz, Fortaz, Tazicef, Tazidime), ceftriaxone (Rocephin), aminoglycosides, and clindamycin (Cleocin) provide this dosing convenience. Newer, expensive antibiotics may also be used such as linezolid and daptomycin.
  • The patient may require repeat aspiration of the bone if fever, pain, and swelling or fail to respond promptly or if radiography reveals significant periosteal elevation or periosteal abscess.
  • If chronicity of illness leads to necrotic bone, surgical debridement is usually required.

Inpatient & Outpatient Medications

It is important to ensure familial compliance with proper dosing of antibiotics when choosing an appropriate oral regimen.



Possible complications from osteomyelitis include disturbances in bone growth, limb-length discrepancies, arthritis, abnormal gait, and pathologic fractures. In patients with chronic osteomyelitis, bone necrosis and fibrosis can occur.



See the list below:

  • Despite adequate treatment and appropriate surgical intervention, 5-10% of patients may experience recurrence.
  • Aggressively treat any recurrence in consultation with an orthopedic surgeon and infectious diseases specialist. Recurrences may lead to chronic osteomyelitis with discharging sinuses and other systemic sequelae.

Patient Education

It is important to discuss age-appropriate care with the patient to ensure compliance with medical therapy.

Contributor Information and Disclosures

Sabah Kalyoussef, DO Attending Physician, Pediatric Infectious Diseases and Hospital Medicine, The Children's Hospital at St Peter's University Hospital

Sabah Kalyoussef, DO is a member of the following medical societies: American Academy of Pediatrics, Infectious Diseases Society of America, Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Joseph Domachowske, MD Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa

Disclosure: Received research grant from: Pfizer;GlaxoSmithKline;AstraZeneca;Merck;American Academy of Pediatrics<br/>Received income in an amount equal to or greater than $250 from: Sanofi Pasteur;Astra Zeneca;Novartis<br/>Consulting fees for: Sanofi Pasteur; Novartis; Merck; Astra Zeneca.

Chief Editor

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.

Additional Contributors

Gary J Noel, MD Professor, Department of Pediatrics, Weill Cornell Medical College; Attending Pediatrician, New York-Presbyterian Hospital

Gary J Noel, MD is a member of the following medical societies: Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

  1. Hollmig ST, Copley LA, Browne RH, Grande LM, Wilson PL. Deep venous thrombosis associated with osteomyelitis in children. J Bone Joint Surg Am. 2007 Jul. 89(7):1517-23. [Medline].

  2. Nourse C, Starr M, Munckhof W. Community-acquired methicillin-resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management. J Paediatr Child Health. 2007 Oct. 43(10):656-61. [Medline].

  3. Belthur MV, Birchansky SB, Verdugo AA, Mason EO Jr, Hulten KG, Kaplan SL, et al. Pathologic fractures in children with acute Staphylococcus aureus osteomyelitis. J Bone Joint Surg Am. 2012 Jan 4. 94(1):34-42. [Medline].

  4. Bouchoucha S, Benghachame F, Trifa M, Saied W, Douira W, Nessib MN, et al. Deep venous thrombosis associated with acute hematogenous osteomyelitis in children. Orthop Traumatol Surg Res. 2010 Dec. 96(8):890-3. [Medline].

  5. Okubo T, Yabe S, Otsuka T, Takizawa Y, Takano T, Dohmae S, et al. Multifocal pelvic abscesses and osteomyelitis from community-acquired methicillin-resistant Staphylococcus aureus in a 17-year-old basketball player. Diagn Microbiol Infect Dis. 2008 Mar. 60(3):313-8. [Medline].

  6. Sdougkos G, Chini V, Papanastasiou DA, Christodoulou G, Tagaris G, Dimitracopoulos G. Methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin as a cause of acute osteomyelitis in children. Clin Microbiol Infect. 2007 Jun. 13(6):651-4. [Medline].

  7. Hawkshead JJ 3rd, Patel NB, Steele RW, Heinrich SD. Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive Staphylococcus aureus. J Pediatr Orthop. 2009 Jan-Feb. 29(1):85-90. [Medline].

  8. Ranson M. Imaging of pediatric musculoskeletal infection. Semin Musculoskelet Radiol. 2009 Sep. 13(3):277-99. [Medline].

  9. Schallert KE, Kan HJ, Monsalve J, et al. Metaphyseal osteomyelitis in children: how often does MRI-documented joint effusion or epiphyseal extension of edema indicate coexisting septic arthritis?. Pediatr Radiol. 2015 Jul. 45 (8):1174-81. [Medline].

  10. Schmit P, Glorion C. Osteomyelitis in infants and children. Eur Radiol. 2004 Mar. 14 Suppl 4:L44-54. [Medline].

  11. Blickman JG, van Die CE, de Rooy JW. Current imaging concepts in pediatric osteomyelitis. Eur Radiol. 2004 Mar. 14 Suppl 4:L55-64. [Medline].

  12. McNeil JC, Forbes AR, Vallejo JG, et al. Role of Operative or Interventional Radiology-Guided Cultures for Osteomyelitis. Pediatrics. May 2016. 137(5):

  13. Mader JT, Shirtliff M, Calhoun JH. Staging and staging application in osteomyelitis. Clin Infect Dis. 1997 Dec. 25(6):1303-9. [Medline].

  14. Chiappini E, Conti C, Galli L, de Martino M. Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review. Clin Ther. 2010 Jan. 32(1):66-88. [Medline].

  15. Zaoutis T, Localio AR, Leckerman K, Saddlemire S, Bertoch D, Keren R. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics. 2009 Feb. 123(2):636-42. [Medline].

  16. Peltola H, Pääkkönen M, Kallio P, Kallio MJ. Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases. Pediatr Infect Dis J. 2010 Dec. 29(12):1123-8. [Medline].

  17. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011 Feb 1. 52(3):285-92. [Medline].

  18. Bachur R, Pagon Z. Success of short-course parenteral antibiotic therapy for acute osteomyelitis of childhood. Clin Pediatr (Phila). 2007 Jan. 46(1):30-5. [Medline].

  19. Jacobs RF, Adelman L, Sack CM, Wilson CB. Management of Pseudomonas osteochondritis complicating puncture wounds of the foot. Pediatrics. 1982 Apr. 69(4):432-5. [Medline].

  20. Ozbek Z, Makay B, Unsal E, Durak I, Gunes D, Anal O. Conjunctival involvement in chronic recurrent multifocal osteomyelitis. Cornea. 2008 Jan. 27(1):117-9. [Medline].

  21. Catalano-Pons C, Raymond J, Chalumeau M, Armengaud JB, Kalifa G, Gendrel D. Case 2: paediatric chronic osteomyelitis: report of two cases. Case 1 diagnosis: pulmonary TB complicated by pneumomediastinum. Case 2 diagnosis: osteomyelitis caused by actinomyces. Acta Paediatr. 2007 Dec. 96(12):1849-52. [Medline].

  22. Asensi V, Alvarez V, Valle E, et al. IL-1alpha (- 889) promoter polymorphism is a risk factor for osteomyelitis. Am J Med Genet. 2003 Jun 1. 119A(2):132-6. [Medline].

  23. Auh JS, Binns HJ, Katz BZ. Retrospective assessment of subacute or chronic osteomyelitis in children and young adults. Clin Pediatr (Phila). 2004 Jul-Aug. 43(6):549-55. [Medline].

  24. Bradley JS, Kaplan SL, Tan TQ, et al. Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG). Pediatrics. 1998 Dec. 102(6):1376-82. [Medline].

  25. Burnett MW, Bass JW, Cook BA. Etiology of osteomyelitis complicating sickle cell disease. Pediatrics. 1998 Feb. 101(2):296-7. [Medline].

  26. Cushing AH. Diskitis in children. Clin Infect Dis. 1993 Jul. 17(1):1-6. [Medline].

  27. Dartnell J, Ramachandran M, Katchburian M. Haematogenous acute and subacute paediatric osteomyelitis: a systematic review of the literature. J Bone Joint Surg Br. 2012 May. 94(5):584-95. [Medline].

  28. Faust SN, Clark J, Pallett A, Clarke NM. Managing bone and joint infection in children. Arch Dis Child. 2012 Jun. 97(6):545-53. [Medline].

  29. Fisher RG. Neonatal osteomyelitis. NeoReviews. July, 2011. 12(7):e374-e380.

  30. Gallagher KT, Roberts RL, MacFarlane JA, Stiehm ER. Treatment of chronic recurrent multifocal osteomyelitis with interferon gamma. J Pediatr. 1997 Sep. 131(3):470-2. [Medline].

  31. Gutierrez K. Bone and joint infections in children. Pediatr Clin North Am. 2005 Jun. 52(3):779-94, vi. [Medline].

  32. Herigon JC, Hersh AL, Gerber JS, Zaoutis TE, Newland JG. Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008. Pediatrics. 2010 Jun. 125(6):e1294-300. [Medline].

  33. Kaplan SL. Osteomyelitis in children. Infect Dis Clin North Am. 2005 Dec. 19(4):787-97, vii. [Medline].

  34. Klein JD, Leach KA. Pediatric pelvic osteomyelitis. Clin Pediatr (Phila). 2007 Nov. 46(9):787-90. [Medline].

  35. Kohli R, Hadley S. Fungal arthritis and osteomyelitis. Infect Dis Clin North Am. 2005 Dec. 19(4):831-51. [Medline].

  36. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med. 1997 Apr 3. 336(14):999-1007. [Medline].

  37. Pääkkönen M, Kallio PE, Kallio MJ, Peltola H. Management of Osteoarticular Infections Caused by Staphylococcus aureus Is Similar to That of Other Etiologies: Analysis of 199 Staphylococcal Bone and Joint Infections. Pediatr Infect Dis J. 2012 May. 31(5):436-8. [Medline].

  38. Raz R, Miron D. Oral ciprofloxacin for treatment of infection following nail puncture wounds of the foot. Clin Infect Dis. 1995 Jul. 21(1):194-5. [Medline].

  39. Schauwecker DS, Braunstein EM, Wheat LJ. Diagnostic imaging of osteomyelitis. Infect Dis Clin North Am. 1990 Sep. 4(3):441-63. [Medline].

  40. Scott RJ, Christofersen MR, Robertson WW Jr, et al. Acute osteomyelitis in children: a review of 116 cases. J Pediatr Orthop. 1990 Sep-Oct. 10(5):649-52. [Medline].

  41. Taylor MN, Chaudhuri R, Davis J, Novelli V, Jaswon MS. Childhood osteomyelitis presenting as a pathological fracture. Clin Radiol. 2008 Mar. 63(3):348-51. [Medline].

  42. Thomsen I, Creech CB. Advances in the diagnosis and management of pediatric osteomyelitis. Curr Infect Dis Rep. 2011 Oct. 13(5):451-60. [Medline].

  43. Unkila-Kallio L, Kallio MJ, Eskola J. Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics. 1994 Jan. 93(1):59-62. [Medline].

  44. Weinstein MP, Stratton CW, Hawley HB, et al. Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis. Am J Med. 1987 Aug. 83(2):218-22. [Medline].

  45. Wong M, Isaacs D, Howman-Giles R, Uren R. Clinical and diagnostic features of osteomyelitis occurring in the first three months of life. Pediatr Infect Dis J. 1995 Dec. 14(12):1047-53. [Medline].

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.